Peter Vaupel

Active 1976–2024

95
Papers
29,125
Citations
76
h-index
93
i10-index

Citations

Citations per year for Peter Vaupel1977: 1 citations1980: 2 citations1981: 2 citations1982: 2 citations1983: 2 citations1984: 12 citations1985: 6 citations1986: 12 citations1987: 10 citations1988: 14 citations1989: 28 citations1990: 20 citations1991: 18 citations1992: 29 citations1993: 59 citations1994: 61 citations1995: 52 citations1996: 71 citations1997: 78 citations1998: 119 citations1999: 112 citations2000: 166 citations2001: 191 citations2002: 156 citations2003: 259 citations2004: 261 citations2005: 218 citations2006: 256 citations2007: 288 citations2008: 272 citations2009: 257 citations2010: 247 citations2011: 195 citations2012: 227 citations2013: 201 citations2014: 212 citations2015: 253 citations2016: 243 citations2017: 204 citations2018: 200 citations2019: 678 citations2020: 842 citations2021: 881 citations2022: 674 citations2023: 510 citations2024: 734 citations2025: 275 citations2026: 5 citations1978–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,282 citing papers, 23.7% of this breakdownChina: 1,610 citing papers, 16.8% of this breakdownUnited Kingdom: 633 citing papers, 6.6% of this breakdownGermany: 603 citing papers, 6.3% of this breakdownItaly: 402 citing papers, 4.2% of this breakdownCanada: 343 citing papers, 3.6% of this breakdownJapan: 299 citing papers, 3.1% of this breakdownNetherlands: 273 citing papers, 2.8% of this breakdownFrance: 223 citing papers, 2.3% of this breakdownSouth Korea: 215 citing papers, 2.2% of this breakdownIndia: 187 citing papers, 2% of this breakdownAustralia: 177 citing papers, 1.8% of this breakdown
0%23.7%Other 24.6%

Fields

  • Biochemistry, Genetics and Molecular Biology48.2%
  • Medicine30.7%
  • Engineering9.8%
  • Immunology and Microbiology3.5%
  • Materials Science2.9%
  • Mathematics1.3%
  • Other3.6%

Topics

  • Cancer, Hypoxia, and Metabolism14.1%
  • Nanoplatforms for cancer theranostics4.5%
  • Cancer Cells and Metastasis2.1%
  • Angiogenesis and VEGF in Cancer1.9%
  • RNA modifications and cancer1.8%
  • Immune cells in cancer1.8%
  • Other73.8%

Coauthors

All papers

Open in search
  1. Revisiting the Warburg effect: historical dogma versus current understanding

    Authors: , - The Journal of Physiology 2020 cited by 811

  2. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression

    Authors: , , - International Journal of Radiation Biology 2019 cited by 894

  3. ESPEN expert group recommendations for action against cancer-related malnutrition

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Nutrition 2017 cited by 1,282

  4. Hypoxia in cancer: significance and impact on clinical outcome

    Authors: , - Cancer and Metastasis Reviews 2007 cited by 2,217

  5. Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects

    Authors: , - JNCI Journal of the National Cancer Institute 2001 cited by 2,663

  6. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

    Authors: , , - 1989 cited by 3,362

  7. Detection and Characterization of Tumor Hypoxia Using pO 2 Histography

    Authors: , , - Antioxidants and Redox Signaling 2007 cited by 735

  8. Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response

    Authors: , - The Oncologist 2004 cited by 753

  9. Tumor microenvironmental physiology and its implications for radiation oncology

    Authors: - Seminars in Radiation Oncology 2004 cited by 950

  10. The Role of Hypoxia-Induced Factors in Tumor Progression

    Authors: - The Oncologist 2004 cited by 827

  11. Tumor Hypoxia and Malignant Progression

    Authors: , , - Methods in enzymology on CD-ROM/Methods in enzymology 2004 cited by 491

  12. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression

    Authors: , - Advances in experimental medicine and biology 2018 cited by 158

  13. Hypoxia Compromises Anti-Cancer Immune Responses

    Authors: , - Advances in experimental medicine and biology 2019 cited by 191

  14. Oxygenation Status of Malignant Tumors vs. Normal Tissues: Critical Evaluation and Updated Data Source Based on Direct Measurements with pO2 Microsensors

    Authors: , , - Applied Magnetic Resonance 2021 cited by 61

  15. From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy

    Authors: , , , , , , , - Cancers 2023 cited by 53

  16. Treatment Resistance of Solid Tumors

    Authors: , , - Medical Oncology 2001 cited by 554

  17. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements.

    Authors: , , , - 1991 cited by 957

  18. NK cell-based therapeutics for lung cancer

    Authors: , , - Expert Opinion on Biological Therapy 2019 cited by 89

  19. Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression

    Authors: , - Advances in experimental medicine and biology 2016 cited by 85

  20. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

    Authors: , , , , , - 1996 cited by 1,746

  21. Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine

    Authors: , - Frontiers in Immunology 2017 cited by 80

  22. How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen‐dependent pathologies

    Authors: , , , , , , , - Physiological Reports 2020 cited by 63

  23. Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis

    Authors: - The Oncologist 2008 cited by 380

  24. Lactate-avid regulatory T cells: metabolic plasticity controls immunosuppression in tumour microenvironment

    Authors: , - Signal Transduction and Targeted Therapy 2021 cited by 40